184 related articles for article (PubMed ID: 24832995)
1. 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry.
Anizan S; Ellefsen K; Concheiro M; Suzuki M; Rice KC; Baumann MH; Huestis MA
Anal Chim Acta; 2014 May; 827():54-63. PubMed ID: 24832995
[TBL] [Abstract][Full Text] [Related]
2. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects.
Anizan S; Concheiro M; Lehner KR; Bukhari MO; Suzuki M; Rice KC; Baumann MH; Huestis MA
Addict Biol; 2016 Mar; 21(2):339-47. PubMed ID: 25475011
[TBL] [Abstract][Full Text] [Related]
3. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.
Baumann MH; Bukhari MO; Lehner KR; Anizan S; Rice KC; Concheiro M; Huestis MA
Curr Top Behav Neurosci; 2017; 32():93-117. PubMed ID: 27830575
[TBL] [Abstract][Full Text] [Related]
4. Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.
Strano-Rossi S; Cadwallader AB; de la Torre X; Botrè F
Rapid Commun Mass Spectrom; 2010 Sep; 24(18):2706-14. PubMed ID: 20814976
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
6. Analytical strategy to investigate 3,4-methylenedioxypyrovalerone (MDPV) metabolites in consumers' urine by high-resolution mass spectrometry.
Ibáñez M; Pozo ÓJ; Sancho JV; Orengo T; Haro G; Hernández F
Anal Bioanal Chem; 2016 Jan; 408(1):151-64. PubMed ID: 26476921
[TBL] [Abstract][Full Text] [Related]
7. Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): Detection, quantification and studies on human metabolism by GC-MS.
Grapp M; Kaufmann C; Ebbecke M
Forensic Sci Int; 2017 Apr; 273():1-9. PubMed ID: 28187296
[TBL] [Abstract][Full Text] [Related]
8. Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS.
Meyer MR; Du P; Schuster F; Maurer HH
J Mass Spectrom; 2010 Dec; 45(12):1426-42. PubMed ID: 21053377
[TBL] [Abstract][Full Text] [Related]
9. New designer drug of abuse: 3,4-Methylenedioxypyrovalerone (MDPV). Findings from apprehended drivers in Finland.
Kriikku P; Wilhelm L; Schwarz O; Rintatalo J
Forensic Sci Int; 2011 Jul; 210(1-3):195-200. PubMed ID: 21477955
[TBL] [Abstract][Full Text] [Related]
10. MDPV in forensic routine cases: Psychotic and aggressive behavior in relation to plasma concentrations.
Diestelmann M; Zangl A; Herrle I; Koch E; Graw M; Paul LD
Forensic Sci Int; 2018 Feb; 283():72-84. PubMed ID: 29275216
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Synthetic Cathinones in Rat Brain Using HILIC-ESI-MS/MS.
Peters JR; Keasling R; Brown SD; Pond BB
J Anal Toxicol; 2016 Nov; 40(9):718-725. PubMed ID: 27474358
[TBL] [Abstract][Full Text] [Related]
12. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
[TBL] [Abstract][Full Text] [Related]
13. Studies on the microbial biotransformation of the novel psychoactive substance methylenedioxypyrovalerone (MDPV) in wastewater by means of liquid chromatography-high resolution mass spectrometry/mass spectrometry.
Mardal M; Meyer MR
Sci Total Environ; 2014 Sep; 493():588-95. PubMed ID: 24982024
[TBL] [Abstract][Full Text] [Related]
14. Rapid and sensitive analysis of 3,4-methylenedioxypyrovalerone in equine plasma using liquid chromatography-tandem mass spectrometry.
Wang CC; Hartmann-Fischbach P; Krueger TR; Wells TL; Feineman AR; Compton JC
J Anal Toxicol; 2012 Jun; 36(5):327-33. PubMed ID: 22582267
[TBL] [Abstract][Full Text] [Related]
15. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
Baumann MH; Partilla JS; Lehner KR; Thorndike EB; Hoffman AF; Holy M; Rothman RB; Goldberg SR; Lupica CR; Sitte HH; Brandt SD; Tella SR; Cozzi NV; Schindler CW
Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of MDPV in rat striatum correlate with the psychostimulant effect.
Novellas J; López-Arnau R; Carbó ML; Pubill D; Camarasa J; Escubedo E
J Psychopharmacol; 2015 Nov; 29(11):1209-18. PubMed ID: 26253621
[TBL] [Abstract][Full Text] [Related]
17. Intoxications involving MDPV in Sweden during 2010-2014: Results from the STRIDA project.
Beck O; Franzen L; Bäckberg M; Signell P; Helander A
Clin Toxicol (Phila); 2015 Nov; 53(9):865-73. PubMed ID: 26462932
[TBL] [Abstract][Full Text] [Related]
18. Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts".
Wyman JF; Lavins ES; Engelhart D; Armstrong EJ; Snell KD; Boggs PD; Taylor SM; Norris RN; Miller FP
J Anal Toxicol; 2013 Apr; 37(3):182-5. PubMed ID: 23408250
[TBL] [Abstract][Full Text] [Related]
19. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.
Berquist MD; Traxler HK; Mahler AM; Baker LE
Drug Alcohol Depend; 2016 Jul; 164():128-134. PubMed ID: 27181413
[TBL] [Abstract][Full Text] [Related]
20. In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV).
Araújo AM; Carvalho M; Costa VM; Duarte JA; Dinis-Oliveira RJ; Bastos ML; Guedes de Pinho P; Carvalho F
Arch Toxicol; 2021 Feb; 95(2):509-527. PubMed ID: 33215236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
